UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$646M |
| 2 |
Automatic Data Processing
ADP
|
+$510M |
| 3 |
Baidu
BIDU
|
+$349M |
| 4 |
Tesla
TSLA
|
+$320M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$758M |
| 2 |
Shopify
SHOP
|
+$568M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$521M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Communication Services | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
1976
LENZ Therapeutics
LENZ
$168M
| $1.23M | ﹤0.01% |
34,493
-2,182
| -6% | -$137K |
|
1977
Quanex
NX
$967M
| $1.23M | ﹤0.01% |
58,472
| – | – |
|
1978
Madrigal Pharmaceuticals
MDGL
$11.9B
| $1.22M | ﹤0.01% |
12,430
| – | – |
|
1979
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $1.22M | ﹤0.01% |
43,684
+10,956
| +33% | +$286K |
|
1980
City Holding Co
CHCO
$2.04B
| $1.22M | ﹤0.01% |
15,486
| – | – |
|
1981
Standard Motor Products
SMP
$885M
| $1.21M | ﹤0.01% |
28,163
+2,572
| +10% | +$121K |
|
1982
ACV Auctions
ACVA
$1.27B
| $1.21M | ﹤0.01% |
81,989
+47,100
| +135% | +$655K |
|
|
CANO
1983
DELISTED
Cano Health, Inc.
CANO
| $1.21M | ﹤0.01% |
1,911
+640
| +50% | +$403K |
|
1984
Pitney Bowes
PBI
$2.33B
| $1.21M | ﹤0.01% |
232,161
-60,371
| -21% | -$327K |
|
1985
Conduent
CNDT
$242M
| $1.2M | ﹤0.01% |
233,321
-3,818
| -2% | -$18.8K |
|
1986
ProPetro Holding
PUMP
$1.43B
| $1.2M | ﹤0.01% |
86,317
+2,162
| +3% | +$25.8K |
|
1987
Malibu Boats
MBUU
$568M
| $1.2M | ﹤0.01% |
20,698
+125
| +0.6% | +$8.05K |
|
1988
Editas Medicine
EDIT
$432M
| $1.2M | ﹤0.01% |
63,086
| – | – |
|
|
FLNA
1989
Filana Therapeutics
FLNA
$48.2M
| $1.19M | ﹤0.01% |
32,109
+5,727
| +22% | +$243K |
|
1990
Establishment Labs
ESTA
$2.21B
| $1.19M | ﹤0.01% |
17,693
+7,175
| +68% | +$420K |
|
|
TWOU
1991
DELISTED
2U Inc
TWOU
| $1.19M | ﹤0.01% |
2,991
+16
| +0.5% | +$6.44K |
|
|
PTRA
1992
DELISTED
Proterra Inc. Common Stock
PTRA
| $1.19M | ﹤0.01% |
158,361
+33,898
| +27% | +$275K |
|
|
MCHB
1993
Mechanics Bancorp
MCHB
$3.7B
| $1.19M | ﹤0.01% |
25,029
+167
| +0.7% | +$8.52K |
|
1994
Codexis
CDXS
$161M
| $1.19M | ﹤0.01% |
57,507
| – | – |
|
|
NGD
1995
DELISTED
New Gold Inc
NGD
| $1.19M | ﹤0.01% |
652,366
+10,010
| +2% | +$17.2K |
|
|
EVOP
1996
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.19M | ﹤0.01% |
51,326
+12,265
| +31% | +$292K |
|
1997
Chefs' Warehouse
CHEF
$4.44B
| $1.18M | ﹤0.01% |
36,327
| – | – |
|
|
CERE
1998
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.18M | ﹤0.01% |
33,822
| – | – |
|
|
TPTX
1999
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.18M | ﹤0.01% |
43,963
| – | – |
|
|
SWTX
2000
DELISTED
SpringWorks Therapeutics
SWTX
| $1.18M | ﹤0.01% |
20,913
| – | – |
|
Similar funds
UBS AM's Q1 2022 Portfolio in Review
As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Baidu worth $306M.
- UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
- UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
- UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
- UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
- UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
- UBS AM opened 60 new positions and closed 124 in Q1 2022.
- UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.